stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / AVNS / Revenue

Avanos Medical, Inc. Revenue 2012–2025

Avanos Medical, Inc. (AVNS) annual revenue by fiscal year, computed from SEC filings. Compound growth -6.5%/yr over 13 years.

Fiscal yearRevenueChange (YoY)
FY 2025$701.20M+1.9%
FY 2024$687.80M+2.2%
FY 2023$673.30M-17.9%
FY 2022$820.00M+39.7%
FY 2021$587.00M-17.9%
FY 2020$714.80M+2.5%
FY 2019$697.60M+6.9%
FY 2018$652.30M+6.7%
FY 2017$611.60M+8.0%
FY 2016$566.20M+11.2%
FY 2015$509.00M-69.6%
FY 2014$1.67B-0.3%
FY 2013$1.68B-0.4%
FY 2012$1.68B

Source: Avanos Medical, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Avanos Medical, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Avanos Medical, Inc. — frequently asked questions

What is Avanos Medical, Inc.'s revenue?

Avanos Medical, Inc. (AVNS) reported revenue of $701.20M for fiscal year 2025, per its SEC filings.

How has Avanos Medical, Inc.'s revenue changed over time?

Between fiscal 2012 and 2025, AVNS's revenue declined at roughly 6.5% per year (compound annual rate), from $1.68B to $701.20M.

Where does this data come from?

Figures are computed from Avanos Medical, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More AVNS financial history

Full AVNS fundamentals page → · All 1,500+ companies →